Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2004

01-06-2004 | Brief Report

Lymphocyte surge as a marker for immunorestitution disease due to Pneumocystis jiroveci pneumonia in HIV-negative immunosuppressed hosts

Authors: V. C. C. Cheng, I. F. N. Hung, A. K. L. Wu, B. S. F. Tang, C. M. Chu, K. Y. Yuen

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2004

Login to get access

Excerpt

Pneumocystis jiroveci (previously known as Pneumocystis carinii f. sp. hominis) pneumonia (PcP) [1] is a well-known opportunistic infection affecting immunocompromised hosts, especially patients infected with HIV. However, with the rising number of patients receiving immunosuppressive therapy, PcP is being increasingly recognised in immunosuppressed hosts who are not infected with HIV [2]. For instance, one previous study found PcP in 3.4–43% of solid organ transplant recipients not infected with HIV, with an especially high incidence among patients on long-term steroid therapy [3]. Though the exact pathogenesis of PcP remains obscure, it has been suggested that immunorestitution disease (IRD) contributes to the manifestation of PcP [4]. Reported here are seven cases of PcP manifesting as IRD in HIV-negative immunosuppressed hosts. …
Literature
1.
go back to reference Stringer JR, Beard CB, Miller RF, Wakefield AE (2002) A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 8:891–896PubMed Stringer JR, Beard CB, Miller RF, Wakefield AE (2002) A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 8:891–896PubMed
2.
go back to reference Arend SM, Kroon FP, van’t Wout JW (1995) Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med 155:2436–2441CrossRefPubMed Arend SM, Kroon FP, van’t Wout JW (1995) Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med 155:2436–2441CrossRefPubMed
3.
go back to reference Sepkowitz KA, Brown AE, Armstrong D (1995) Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. Arch Intern Med 155:1125–1128CrossRefPubMed Sepkowitz KA, Brown AE, Armstrong D (1995) Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. Arch Intern Med 155:1125–1128CrossRefPubMed
4.
go back to reference Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM (2000) Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30:882–892PubMed Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM (2000) Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30:882–892PubMed
5.
go back to reference Wislez M, Bergot E, Antoine M, Parrot A, Carette MF, Mayaud C, Cadranel J (2001) Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 164:847–851PubMed Wislez M, Bergot E, Antoine M, Parrot A, Carette MF, Mayaud C, Cadranel J (2001) Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 164:847–851PubMed
6.
go back to reference Dean GL, Williams DI, Churchill DR, Fisher MJ (2002) Transient clinical deterioration in HIV patients with Pneumocystis carinii pneumonia after starting highly active antiretroviral therapy: another case of immune restoration inflammatory syndrome. Am J Respir Crit Care Med 165:1670 Dean GL, Williams DI, Churchill DR, Fisher MJ (2002) Transient clinical deterioration in HIV patients with Pneumocystis carinii pneumonia after starting highly active antiretroviral therapy: another case of immune restoration inflammatory syndrome. Am J Respir Crit Care Med 165:1670
7.
go back to reference Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D (1992) Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. J Am Med Assoc 267:832–837CrossRef Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D (1992) Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. J Am Med Assoc 267:832–837CrossRef
8.
go back to reference Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AO (1991) Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 48:406–409PubMed Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AO (1991) Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 48:406–409PubMed
9.
go back to reference Slivka A, Wen PY, Shea WM, Loeffler JS (1993) Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med 94:216–219CrossRefPubMed Slivka A, Wen PY, Shea WM, Loeffler JS (1993) Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med 94:216–219CrossRefPubMed
10.
go back to reference Cheng VC, Yuen KY, Wong SS, Woo PC, Ho PL, Lee R, Chan RM (2001) Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 20:402–406PubMed Cheng VC, Yuen KY, Wong SS, Woo PC, Ho PL, Lee R, Chan RM (2001) Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 20:402–406PubMed
11.
go back to reference Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY (2002) Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21:803–809CrossRefPubMed Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY (2002) Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21:803–809CrossRefPubMed
Metadata
Title
Lymphocyte surge as a marker for immunorestitution disease due to Pneumocystis jiroveci pneumonia in HIV-negative immunosuppressed hosts
Authors
V. C. C. Cheng
I. F. N. Hung
A. K. L. Wu
B. S. F. Tang
C. M. Chu
K. Y. Yuen
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2004
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1140-6

Other articles of this Issue 6/2004

European Journal of Clinical Microbiology & Infectious Diseases 6/2004 Go to the issue

Announcements

June 2004

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.